Clinical trials
Recruiting Neuromyelitis Optica trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 2 |
| Amgen | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| Ad scientiam | 1 |
| Anastasia Vishnevetsky, MD, MPH | 1 |
| Cedars-Sinai Medical Center | 1 |
| Charles M Knudson | 1 |
| Hoffmann-La Roche | 1 |
| MD Stem Cells | 1 |
| TG Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromyelitis Optica | 14 |
| Multiple Sclerosis | 4 |
| Myasthenia Gravis | 2 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 |
| Atypical Hemolytic Uremic Syndrome | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Blindness | 1 |
| Cone Dystrophy | 1 |
| Cone-Rod Dystrophies | 1 |
| Demyelinating Autoimmune Diseases, CNS | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.